Combination Therapy Current Events | Combination Therapy News | 5
|
| Page
5 of
50 |
998 Results |
|
|
|
Sort By:
Page Views | Date |
New therapy may mean less dietary restrictions for celiac sufferers
Scientists have discovered what may be a successful non-dietary therapy for celiac sprue, an inherited inflammatory disorder of the small intestine that impacts an estimated 1 in 200 people around the world. view more (2006-06-26)
Study confirms benefit of combination therapy for Alzheimer's disease
Extended treatment with Alzheimer's disease drugs can significantly slow the rate at which the disorder advances, and combination therapy with two different classes of drugs is even better at helping patients maintain their ability to perform daily activities. view more (2008-09-22)
Identifying the potential for tamoxifen resistance in patients
Tamoxifen is a widely used and highly successful drug in the treatment of breast cancer, though resistance to tamoxifen is still a concern in recurrent disease (affecting 25-35% of patients), since therapy resistant metastatic tumor cells are a major cause of death. view more (2009-06-11)
Study of revlimid and vidaza in higher-risk MDS is well-tolerated and has high activity
Celgene International Sarl (NASDAQ: CELG) reported that results of a Phase I study presented today combining REVLIMID and VIDAZA in patients with higher-risk myelodysplastic syndromes (MDS) found that the combination of these two therapies is well tolerated and has high activity. view more (2008-12-11)
Modern radiation therapy ups lung cancer survival
Modern three-dimensional radiation therapy has been proven to be more successful at curing lung cancer than older two-dimensional radiation therapy for some patients with early stage lung cancer. view more (2006-09-01)
Combining targeted therapy drugs may treat previously resistant tumors
A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches. view more (2008-12-01)
Combination Anti-Clotting Therapy Increases Risk Of Bleeding For People At High Risk of Recurrent Stroke
The combination of two anti-clotting agents, aspirin and clopidogrel- known to be beneficial for people with cardiovascular disease-should not be recommended treatment for patients who have cerebrovascular disease, conclude authors of a study in this week's issue of THE LANCET. Hans-Christoph Diener (University of Essen, Germany) and colleagues... view more... (2004-07-21)
Photodynamic therapy effective for certain head and neck cancers
A combination of medications and a particular light therapy is effective at treating certain types of head and neck cancers in subtropical climates. view more (2009-10-05)
Study shows chemotherapy improves survival among older breast cancer patients
The average age of a woman diagnosed with breast cancer is 63, so it is critical to have effective proven, therapies for an older patient population. view more (2009-05-14)
Inappropriate sepsis therapy leads to fivefold reduction in survival
Patients experiencing septic shock who receive inappropriate therapy may have a fivefold reduction in survival, shows a new study. view more (2009-11-05)
Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers
The addition of a chemotherapeutic drug for leukemia to a standard regimen of two other chemotherapy drugs appears to enhance the response of certain ovarian cancers to treatment, according to a pre-clinical study led by researchers in the Duke Comprehensive Cancer Center. view more (2009-04-20)
Low-dose chemotherapy plus antiangiogenesis drug has activity in advanced breast cancer
Chemotherapy given in low, frequent doses - a novel strategy called "metronomic" delivery - achieved partial shrinkage of disease in some advanced breast cancer patients when given concurrently with an angiogenesis inhibitor. view more (2005-12-09)
New antibiotic drug combo to speed up treatment of tuberculosis
A team of tuberculosis (TB) experts at Johns Hopkins and in Brazil have evidence that substituting the antibiotic moxifloxacin in the regimen of drugs used to treat the highly contagious form of lung disease could dramatically shorten the time needed to cure the illness from six months to four. view more (2007-09-19)
A new approach to the treatment of malaria in pregnant women in West Africa
A new approach to treatment for pregnant women suffering from malaria in west Africa has been found to be both safe and effective, following a randomised trial carried out by a team based in Ghana and at the London School of Hygiene & Tropical Medicine (LSHTM). view more (2006-10-13)
Three-in-one virus killer prevents common, often fatal infections
A novel combination therapy drastically reduces the infection rate of three viruses - and risk of death - in transplant patients with compromised immune systems. view more (2006-10-27)
Cost-benefit analysis: Combo treatment costs more, saves money later
From a health insurer's perspective, the most effective cancer treatment may also be the most cost-effective. view more (2006-11-08)
Experimental chemotherapy regimen shows promise in treating advanced lung cancer
A combination of chemotherapy agents that have been tested in other tumor types appears to be a promising alternative to standard treatment for advanced non-small cell lung cancer, according to a report in the August 15 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research. view more (2008-08-12)
Lowering of Blood Pressure Reduces Risk of Recurrent Stroke (pp 1026, 1033)
Combination drug treatment to lower blood pressure could substantially reduce the risk of recurrent stroke, conclude authors of a fast-track study published in this week's issue of The Lancet. Each year stroke effects 20 million people worldwide, kills 5 million people, and a third of 15 million non-fatal strokes result in severe disability. For... view more... (2001-09-26)
Sitting and thinking, or just sitting?
Patients recovering from brain injuries such as strokes often experience difficulties carrying out two activities at the same time, according to researchers in the School of Psychology at the University of Reading. Most of us can walk, cycle or drive and carry on a conversation at the same time because the combination of motor actions is so... view more... (2004-03-19)
Unique drug combination may hold the key to reversing Type I diabetes
Promising results from a study that tested a new approach for reversing Type 1 diabetes are being presented this week at the American Diabetes Association's 68th Annual Scientific Session in San Francisco. view more (2008-06-11)
|
|
| Page
5 of
50 |
998 Results |
|
|
|
Sort By:
Page Views | Date |
|
